Anup K.Thacker, Professor, Dr. RML Institute of Medical Sciences, Lucknow, Indiaanupthacker@yahoo.co.in
Submitted July 16, 2015
I read Dr. Pulst's introduction with interest. I am always
fascinated by the findings of genetic studies in any disease. These studies are expensive,
but enable physicians to resolve unanswered questions presented by the illness.
Variations in the phenotypic presentations of the same disease entity can also further
our understanding of that disease. However, from the patient's point of view, it would
appear that these studies--while leading physicians to a definitive diagnosis--still offer
no effective treatment. Unless there is access to genetic engineering at a field level,
genetics may not seem like a cost-effective proposition in resource-poor countries.
1. Pulst SM. Welcome to Neurology: Genetics. Neurol Genet June 2015;1:e2.
For disclosures, please contact the editorial office at ngjournal@neurology.org.
I read Dr. Pulst's introduction with interest. I am always fascinated by the findings of genetic studies in any disease. These studies are expensive, but enable physicians to resolve unanswered questions presented by the illness. Variations in the phenotypic presentations of the same disease entity can also further our understanding of that disease. However, from the patient's point of view, it would appear that these studies--while leading physicians to a definitive diagnosis--still offer no effective treatment. Unless there is access to genetic engineering at a field level, genetics may not seem like a cost-effective proposition in resource-poor countries.
1. Pulst SM. Welcome to Neurology: Genetics. Neurol Genet June 2015;1:e2.
For disclosures, please contact the editorial office at ngjournal@neurology.org.